PHAXIAM Therapeutics S.A. Euronext Paris
Equities
PHXM
FR0011471135
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 EUR | +0.17% | -0.68% | -36.09% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.97% | 103B | |
+2.15% | 96.56B | |
+1.72% | 22.61B | |
-17.53% | 21.18B | |
-4.50% | 19.07B | |
-41.75% | 16.53B | |
-25.41% | 14.46B | |
+2.13% | 13.25B | |
+22.48% | 11.1B |
- Stock Market
- Equities
- PHXM Stock
- PHXM Stock
- News PHAXIAM Therapeutics S.A.
- Erytech Pharma Gets US Patent For Methioninase, Asparaginase in Solid Tumor Treatment